Alain Latil

2.3k total citations
40 papers, 1.5k citations indexed

About

Alain Latil is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Alain Latil has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 19 papers in Pulmonary and Respiratory Medicine and 14 papers in Cancer Research. Recurrent topics in Alain Latil's work include Prostate Cancer Treatment and Research (18 papers), Genetic factors in colorectal cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Alain Latil is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Genetic factors in colorectal cancer (6 papers) and Cancer-related molecular mechanisms research (5 papers). Alain Latil collaborates with scholars based in France, United States and Germany. Alain Latil's co-authors include Olivier Cussenot, Georges Fournier, Rosette Lidereau, Philippe Berthon, Philippe Mangin, Laurent Chêne, Michel Vidaud, Antoine Valéri, Sandrine Pesche and Keltouma Driouch and has published in prestigious journals such as Cancer, Oncogene and The Journal of Urology.

In The Last Decade

Alain Latil

40 papers receiving 1.5k citations

Peers

Alain Latil
Bryan K. McCune United States
Eeva Valve Finland
Jay D. Hunt United States
Debra M. Sutkowski United States
Bryan K. McCune United States
Alain Latil
Citations per year, relative to Alain Latil Alain Latil (= 1×) peers Bryan K. McCune

Countries citing papers authored by Alain Latil

Since Specialization
Citations

This map shows the geographic impact of Alain Latil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain Latil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain Latil more than expected).

Fields of papers citing papers by Alain Latil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain Latil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain Latil. The network helps show where Alain Latil may publish in the future.

Co-authorship network of co-authors of Alain Latil

This figure shows the co-authorship network connecting the top 25 collaborators of Alain Latil. A scholar is included among the top collaborators of Alain Latil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain Latil. Alain Latil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hewitt, Nicola J., Robert J. Edwards, Ellen Fritsche, et al.. (2013). Use of Human In Vitro Skin Models for Accurate and Ethical Risk Assessment: Metabolic Considerations. Toxicological Sciences. 133(2). 209–217. 76 indexed citations
2.
Latil, Alain, et al.. (2012). Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP‐1/CCL2 and VCAM‐1, in vitro. British Journal of Urology. 110(6b). E301–7. 43 indexed citations
3.
D’Anjou, François, Sophie Routhier, Jean‐Pierre Perreault, et al.. (2011). Molecular Validation of PACE4 as a Target in Prostate Cancer. Translational Oncology. 4(3). 157–IN9. 58 indexed citations
4.
Dubosq, Francis, Guillaume Ploussard, Hany Soliman, et al.. (2011). Identification of a three-gene expression signature of early recurrence in non-muscle-invasive urothelial cell carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 30(6). 833–840. 14 indexed citations
5.
Fromont, Gaëlle, Antoine Valéri, Michael L. Cher, et al.. (2005). Allelic loss at 16q23.2 is associated with good prognosis in high grade prostate cancer. The Prostate. 65(4). 341–346. 4 indexed citations
6.
Valéri, Antoine, Gaëlle Fromont, Wael Sakr, et al.. (2005). High frequency of allelic losses in high-grade prostate cancer is associated with biochemical progression after radical prostatectomy. Urologic Oncology Seminars and Original Investigations. 23(2). 87–92. 4 indexed citations
7.
Chêne, Laurent, C. Giroud, François Desgrandchamps, et al.. (2004). Extensive analysis of the 7q31 region in human prostate tumors supports TES as the best candidate tumor suppressor gene. International Journal of Cancer. 111(5). 798–804. 35 indexed citations
8.
Fromont, Gaëlle, Laurent Chêne, Michel Vidaud, et al.. (2004). Differential expression of 37 selected genes in hormone‐refractory prostate cancer using quantitative taqman real‐time RT‐PCR. International Journal of Cancer. 114(2). 174–181. 15 indexed citations
10.
Cancel‐Tassin, Géraldine, Alain Latil, Francis Rousseau, et al.. (2003). Association Study of Polymorphisms in the Human Estrogen Receptor Alpha Gene and Prostate Cancer Risk. European Urology. 44(4). 487–490. 24 indexed citations
11.
Latil, Alain, Laurent Chêne, Philippe Mangin, et al.. (2003). Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion. The Prostate. 57(1). 39–50. 34 indexed citations
12.
Naïmi, Benyoussef, Alain Latil, Georges Fournier, et al.. (2002). Down‐regulation of (IIIb) and (IIIc) isoforms of fibroblast growth factor receptor 2 (FGFR2) is associated with malignant progression in human prostate. The Prostate. 52(3). 245–252. 61 indexed citations
13.
14.
Cancel‐Tassin, Géraldine, Alain Latil, Antoine Valéri, et al.. (2001). PCAP is the major known prostate cancer predisposing locus in families from south and west Europe. European Journal of Human Genetics. 9(2). 135–142. 43 indexed citations
15.
Latil, Alain, et al.. (2001). Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways. Cancer. 92(5). 1130–1137. 155 indexed citations
16.
Pesche, Sandrine, Alain Latil, Françoise Muzeau, et al.. (1998). PTEN/MMAC1/TEP1 involvement in primary prostate cancers. Oncogene. 16(22). 2879–2883. 104 indexed citations
17.
Latil, Alain, Ivan Bièche, Georges Fournier, et al.. (1998). Molecular analysis of the FHIT gene in human prostate cancer. Oncogene. 16(14). 1863–1868. 22 indexed citations
18.
Latil, Alain, et al.. (1994). Oncogene amplifications in early‐stage human prostate carcinomas. International Journal of Cancer. 59(5). 637–638. 31 indexed citations
19.
Latil, Alain, Olivier Cussenot, Georges Fournier, et al.. (1994). Genetic alterations in localized prostate cancer: Identification of a common region of deletion on chromosome arm 18q. Genes Chromosomes and Cancer. 11(2). 119–125. 70 indexed citations
20.
Champème, M.H., et al.. (1992). Association between restriction fragment length polymorphism of the L‐myc gene and lung metastasis in human breast cancer. International Journal of Cancer. 50(1). 6–9. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026